The contributions of RET noncoding variation to Hirschsprung disease

Zachary E. Stine, Andrew S McCallion

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

First described by Danish pediatrician Harald Hirschsprung, Hirschsprung disease (HSCR) is a disorder of the enteric nervous system characterized by the absence of variable length of the submucous (Meissner's) and myenteric (Auerbach's) plexuses in the distal gut. As a defect in neural crest-derived cell population, Hirschsprung disease is considered a neurocristopathy. While HSCR was originally observed in sporadic cases, the advent of lifesaving surgical intervention has also given rise to the observation of familial forms of HSCR. Subsequently, its presentation in familial, sporadic, and syndromic form illuminated the genetics of HSCR. As this work has progressed the ret proto-oncogene (RET), a receptor tyrosine kinase has emerged as a central player in the development of HSCR, most frequently modified in effect by the contributions of risk alleles at other loci. This has been exemplified by the recent characterization of risk variants in a noncoding RET regulatory element, establishing it as a model for the study of multigenic disorders.

Original languageEnglish (US)
Title of host publicationGene Regulatory Sequences and Human Disease
PublisherSpringer New York
Pages169-194
Number of pages26
ISBN (Print)9781461416838, 1461416825, 9781461416821
DOIs
StatePublished - Sep 1 2011

Fingerprint

Hirschsprung Disease
Myenteric Plexus
Proto-Oncogene Proteins c-ret
Enteric Nervous System
Inborn Genetic Diseases
Proto-Oncogenes
Neural Crest
Receptor Protein-Tyrosine Kinases
Neurology
Alleles
Cells
Observation
Defects
Population

Keywords

  • Cis-regulatory element
  • Disease
  • Enhancer
  • Enteric nervous system
  • Hirschsprung
  • Neural crest
  • NRG1
  • RET
  • SOX10
  • Transcriptional regulation

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Stine, Z. E., & McCallion, A. S. (2011). The contributions of RET noncoding variation to Hirschsprung disease. In Gene Regulatory Sequences and Human Disease (pp. 169-194). Springer New York. https://doi.org/10.1007/978-1-4614-1683-8_9

The contributions of RET noncoding variation to Hirschsprung disease. / Stine, Zachary E.; McCallion, Andrew S.

Gene Regulatory Sequences and Human Disease. Springer New York, 2011. p. 169-194.

Research output: Chapter in Book/Report/Conference proceedingChapter

Stine, ZE & McCallion, AS 2011, The contributions of RET noncoding variation to Hirschsprung disease. in Gene Regulatory Sequences and Human Disease. Springer New York, pp. 169-194. https://doi.org/10.1007/978-1-4614-1683-8_9
Stine ZE, McCallion AS. The contributions of RET noncoding variation to Hirschsprung disease. In Gene Regulatory Sequences and Human Disease. Springer New York. 2011. p. 169-194 https://doi.org/10.1007/978-1-4614-1683-8_9
Stine, Zachary E. ; McCallion, Andrew S. / The contributions of RET noncoding variation to Hirschsprung disease. Gene Regulatory Sequences and Human Disease. Springer New York, 2011. pp. 169-194
@inbook{fee135ec01ea4936967320a7138c072c,
title = "The contributions of RET noncoding variation to Hirschsprung disease",
abstract = "First described by Danish pediatrician Harald Hirschsprung, Hirschsprung disease (HSCR) is a disorder of the enteric nervous system characterized by the absence of variable length of the submucous (Meissner's) and myenteric (Auerbach's) plexuses in the distal gut. As a defect in neural crest-derived cell population, Hirschsprung disease is considered a neurocristopathy. While HSCR was originally observed in sporadic cases, the advent of lifesaving surgical intervention has also given rise to the observation of familial forms of HSCR. Subsequently, its presentation in familial, sporadic, and syndromic form illuminated the genetics of HSCR. As this work has progressed the ret proto-oncogene (RET), a receptor tyrosine kinase has emerged as a central player in the development of HSCR, most frequently modified in effect by the contributions of risk alleles at other loci. This has been exemplified by the recent characterization of risk variants in a noncoding RET regulatory element, establishing it as a model for the study of multigenic disorders.",
keywords = "Cis-regulatory element, Disease, Enhancer, Enteric nervous system, Hirschsprung, Neural crest, NRG1, RET, SOX10, Transcriptional regulation",
author = "Stine, {Zachary E.} and McCallion, {Andrew S}",
year = "2011",
month = "9",
day = "1",
doi = "10.1007/978-1-4614-1683-8_9",
language = "English (US)",
isbn = "9781461416838",
pages = "169--194",
booktitle = "Gene Regulatory Sequences and Human Disease",
publisher = "Springer New York",

}

TY - CHAP

T1 - The contributions of RET noncoding variation to Hirschsprung disease

AU - Stine, Zachary E.

AU - McCallion, Andrew S

PY - 2011/9/1

Y1 - 2011/9/1

N2 - First described by Danish pediatrician Harald Hirschsprung, Hirschsprung disease (HSCR) is a disorder of the enteric nervous system characterized by the absence of variable length of the submucous (Meissner's) and myenteric (Auerbach's) plexuses in the distal gut. As a defect in neural crest-derived cell population, Hirschsprung disease is considered a neurocristopathy. While HSCR was originally observed in sporadic cases, the advent of lifesaving surgical intervention has also given rise to the observation of familial forms of HSCR. Subsequently, its presentation in familial, sporadic, and syndromic form illuminated the genetics of HSCR. As this work has progressed the ret proto-oncogene (RET), a receptor tyrosine kinase has emerged as a central player in the development of HSCR, most frequently modified in effect by the contributions of risk alleles at other loci. This has been exemplified by the recent characterization of risk variants in a noncoding RET regulatory element, establishing it as a model for the study of multigenic disorders.

AB - First described by Danish pediatrician Harald Hirschsprung, Hirschsprung disease (HSCR) is a disorder of the enteric nervous system characterized by the absence of variable length of the submucous (Meissner's) and myenteric (Auerbach's) plexuses in the distal gut. As a defect in neural crest-derived cell population, Hirschsprung disease is considered a neurocristopathy. While HSCR was originally observed in sporadic cases, the advent of lifesaving surgical intervention has also given rise to the observation of familial forms of HSCR. Subsequently, its presentation in familial, sporadic, and syndromic form illuminated the genetics of HSCR. As this work has progressed the ret proto-oncogene (RET), a receptor tyrosine kinase has emerged as a central player in the development of HSCR, most frequently modified in effect by the contributions of risk alleles at other loci. This has been exemplified by the recent characterization of risk variants in a noncoding RET regulatory element, establishing it as a model for the study of multigenic disorders.

KW - Cis-regulatory element

KW - Disease

KW - Enhancer

KW - Enteric nervous system

KW - Hirschsprung

KW - Neural crest

KW - NRG1

KW - RET

KW - SOX10

KW - Transcriptional regulation

UR - http://www.scopus.com/inward/record.url?scp=84929271472&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929271472&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-1683-8_9

DO - 10.1007/978-1-4614-1683-8_9

M3 - Chapter

AN - SCOPUS:84929271472

SN - 9781461416838

SN - 1461416825

SN - 9781461416821

SP - 169

EP - 194

BT - Gene Regulatory Sequences and Human Disease

PB - Springer New York

ER -